IL1B and cancer: Six core targets (TP53, CCND1, IL-1β, etc.) were identified. Molecular docking and in vitro experiments confirmed that matrine upregulates TP53 while downregulating CCND1 and IL1B, effectively inhibiting cancer cell proliferation and migration while mitigating inflammatory responses